Jiangsu Hengrui Medicine
600276.SS
#467
Rank
HK$342.00 B
Marketcap
HK$53.61
Share price
-1.00%
Change (1 day)
3.24%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of September 2024 : HK$25.40 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has HK$25.40 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31HK$20.24 B-11.63%
2021-12-31HK$22.90 B17.29%
2020-12-31HK$19.53 B29.17%
2019-12-31HK$15.12 B19%
2018-12-31HK$12.70 B147.96%
2017-12-31HK$5.12 B-6.58%
2016-12-31HK$5.48 B-10.64%
2015-12-31HK$6.13 B42.08%
2014-12-31HK$4.32 B55.45%
2013-12-31HK$2.77 B68.16%
2012-12-31HK$1.65 B40.88%
2011-12-31HK$1.17 B0.18%
2010-12-31HK$1.17 B45.87%
2009-12-31HK$0.80 B52.16%
2008-12-31HK$0.52 B-41.49%
2007-12-31HK$0.90 B57%
2006-12-31HK$0.57 B38.55%
2005-12-31HK$0.41 B21.33%
2004-12-31HK$0.34 B81.24%
2003-12-31HK$0.18 B4.56%
2002-12-31HK$0.18 B-29.37%
2001-12-31HK$0.25 B-43.98%
2000-12-31HK$0.45 B389.33%
1999-12-31HK$93.13 M247.62%
1998-12-31HK$26.79 M8.64%
1997-12-31HK$24.65 M